Skip to main content

Publicis Sued For Deceptive Opioid Marketing

Publicis Sued For Deceptive Opioid Marketing

Publicis Sued For Deceptive Opioid Marketing

Introduction

A Massachusetts attorney general has sued Publicis Health, LLC, alleging that the company helped Purdue Pharma in selling more OxyContin by deploying unfair and deceptive marketing schemes resulting in the opioid crisis.

The complaint is filed in Suffolk Superior Court alleged that Publicis partnered with Purdue to boost its opioids sales by recommending the doctors to prescribe Purdue’s opioids to more patients, in higher doses, for longer periods of time. Publicis garnered dozens of contracts with Purdue from 2010 to 2019 and collected more than $50 million for opioid marketing.

The attorney general explained Purdue fueled the opioid crisis in Massachusetts that resulted in death and overdose of the drug among the patients. She even stated that Publicis should also be equally blamed for the crisis, as it convinced the doctors to prescribe more OxyContin to more patients.

Publicis faces numerous allegations in the lawsuit, including deceptive marketing strategies and sending thousands of unfair emails to the prescribers along with the doctors to boost opioid use among the patients. Publicis even placed ads for OxyContin right in patients’ electronic medical records. The company even created stories to market the drugs and boost the sales of Purdue.

This lawsuit is a perfect way to combat the opioid epidemic and deal with the culprits who fueled the crisis. The attorney general will focus on dealing with the crisis through a multi-disciplinary approach that includes enforcement, policy, prevention, and education efforts. 

The attorney general even led a $573 million settlement along with 53 attorneys general against McKinsey & Company for helping Purdue to promote opioid sales. She even sued the Sackler family in June 2018 for creating the opioid crisis.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Supreme Court Upholds Flavored Vape Ban

Categories: E-Cigarette: JUUL

The U.S. Supreme Court has unanimously upheld a decision by the Food and Drug Administration (FDA) to block the sale and marketing of certain flavored e-cigarette products.

The ruling supports the FDA’s authority to regulate tobacco…

Judge Rejects JnJ's $10B Talc Lawsuit Settlement

Categories: Talcum

Johnson & Johnson's shares fell more than 5% after a U.S. bankruptcy judge rejected its $10 billion settlement proposal aimed at resolving over 60,000 lawsuits. 

These lawsuits allege that the company’s…

Tepezza Hearing Loss MDL: Bellwether Trials Set for 2026

Categories: Tepezza

A U.S. District Judge overseeing Tepezza hearing damage lawsuits nationwide has scheduled four bellwether trials for 2026. These trials are intended to help both parties assess how juries may respond to the evidence and testimonies that could be…

🛠️ You Have Unfinished Work. We’ll Finish It — Free Trial.            
Free Trial + 25% Off All DLs & Med Review Case Backlog!

Only 12 Firms Can Join – First Come, First Served